Scientific developments
Developments in cancer science, with an honest line between early research and established care.
Every page here follows one idea: what happened, why it matters, and what it does not mean. Educational only — not medical advice.
- Cancer prevention vaccines · 2026Vaccines to Prevent Cancer Before It Starts: What Is Proven and What Is Being StudiedSome vaccines already prevent infections that can cause cancer. Vaccines aimed directly at precancer or inherited risk remain research tools.
- Tumor microenvironment · 2026The Tumor Microenvironment: Why Cancer Research Looks Beyond Tumor CellsTumors interact with immune cells, blood vessels, connective tissue, and signals around them. That environment may affect treatment response.
- Triple-negative breast cancer · 2026Triple-Negative Breast Cancer Research: Why One Label Covers Different TumorsTriple-negative breast cancer lacks three common treatment targets, but other biomarkers and disease settings can still guide research and care.
- Sleep and yoga in survivorship · 2026Sleep and Yoga Studies in Cancer Survivorship: Helpful Support, Not a Cancer TreatmentYoga and behavioral sleep programs may improve sleep or mood for some survivors. They do not treat the cancer itself.
- Rare cancer research · 2026Rare-Cancer Research: Why Shared Data and Basket Trials MatterRare cancers make large studies difficult. Networks, shared data, and biomarker-based trials can help, but small numbers require cautious conclusions.
- Quality of life in cancer research · 2026Quality of Life in Cancer Trials: Why This Outcome Belongs Beside SurvivalCancer trials may measure symptoms, daily function, and quality of life along with tumor response and survival. Each outcome answers a different question.
- PROTAC cancer research · 2026PROTACs and Targeted Protein Degradation: What the Cancer Research MeansPROTACs are designed to direct unwanted proteins toward the cell's disposal system. Clinical benefit still must be demonstrated in trials.
- Prevention and treatment cancer vaccines · 2026Cancer Vaccines: Prevention and Treatment Are Two Different GoalsHPV and hepatitis B vaccines prevent infections linked to cancer. Treatment vaccines try to help the immune system attack an existing cancer.
- Precision oncology · 2026Precision Oncology Is Moving Beyond One Gene and One DrugPrecision oncology increasingly combines tumor genes, proteins, images, and clinical details. More data do not guarantee a useful treatment match.
- Personalized cancer vaccines · 2026Personalized Cancer Vaccines: What They Are and Why They Are Still ExperimentalPersonalized cancer vaccines are designed around features of a person's tumor. Most remain experimental and must be tested in clinical trials.
- Patient-reported outcomes · 2026Patient-Reported Outcomes: When the Patient's Own Report Becomes DataPatient-reported outcomes measure symptoms and daily function directly from patients. Collecting data helps only when teams review and act on it.
- Pancreatic cancer precision oncology · 2026Pancreatic Cancer, KRAS, and Precision Oncology: The Full Story Behind the HeadlinesKRAS research shows how tumor biology can guide drug development. Testing, eligibility, approval status, benefit, and harms must be considered together.
- Pancreatic cancer and KRAS · 2026KRAS-Targeted Treatment for Pancreatic Cancer: How to Read the HeadlinesKRAS-targeted pancreatic cancer results are drawing attention. Here is what targeted treatment means and what early headlines cannot establish.
- Next-generation immunotherapy · 2026Next-Generation Immunotherapy: What Researchers Are Trying to ImproveResearchers are studying ways to make immunotherapy work in more cancers and more people while reducing serious immune-related side effects.
- Multi-cancer tests and screening · 2026Multi-Cancer Blood Tests, False Positives, and the Screening You Still NeedA multi-cancer blood test makes a prediction, not a diagnosis. It does not replace established screening and may lead to more testing.
- Multi-cancer detection tests · 2026Multi-Cancer Blood Tests in 2026: What Is Known and What Is Still UnclearMulti-cancer detection tests look for cancer signals in blood. Federal sources say their effect on cancer deaths is not yet known.
- Molecular glues · 2026Molecular Glues in Cancer Research: A New Strategy, Not Yet a Broad TreatmentMolecular glues change how proteins interact inside cells. Most cancer uses remain early research rather than established patient care.
- HER2 biomarkers · 2026HER2-Low, HER2-Positive, and HER2-Mutated: Similar Words, Different Treatment QuestionsHER2 can be measured or changed in different ways. A headline about one HER2 category may not apply to another.
- Exercise and cancer care · 2026Exercise During and After Cancer Treatment: What Research Can Reasonably SayPhysical activity may support strength, function, fatigue, and well-being. The safest plan depends on treatment, symptoms, and ability.
- Digital pathology · 2026Digital Pathology and AI: How Cancer Slides Are Becoming DataDigital pathology turns microscope slides into high-resolution images. AI may help analyze them, but pathologists remain responsible for diagnosis.
- Circulating tumor DNA and residual disease · 2026ctDNA and Minimal Residual Disease: Why the Blood-Test Headlines Need ContextctDNA tests may detect tumor DNA after treatment. What a result means—and whether it should change care—depends on the cancer and evidence.
- Cell therapy for blood cancers · 2026Cell Therapies for Blood Cancers: CAR-T, TCR, TIL, and Donor Cells Are Not the SameCell-therapy headlines use similar language for different treatments. The cell source, engineering, target, cancer, and risks all matter.
- CAR-T therapy for solid tumors · 2026CAR-T Therapy for Solid Tumors: Why Progress Has Been DifficultCAR-T therapy has changed care for some blood cancers. Solid tumors pose different targeting and immune-environment problems.
- Cancer in younger adults · 2026Cancer in Younger Adults: What the Data Show and What They Do Not ExplainRates of some cancers are rising in younger adults, but cancer overall remains strongly linked with older age and the causes are not fully known.
- Blood tests and immunotherapy response · 2026Can a Blood Test Predict Immunotherapy Response? What Proof Is Still NeededBlood-based tumor profiling may help researchers study immunotherapy response. Proof of concept is not yet a routine clinical test.
- Bispecific antibodies · 2026Bispecific Antibodies in Cancer Treatment: Two Targets, More QuestionsBispecific antibodies can bind two targets at once, often bringing immune cells close to cancer cells. Each product needs its own evidence.
- Cancer biomarkers · 2026A Complete Guide to Biomarker Headlines: Test, Target, Drug, and EvidenceA biomarker can help classify cancer or guide treatment, but only when the test, result, drug, and evidence fit the same clinical situation.
- Antibody-drug conjugates · 2026Why Antibody–Drug Conjugates Are Appearing in So Many Cancer HeadlinesAntibody–drug conjugates combine a targeting antibody with a cancer-killing drug. Their benefits and risks depend on the target, cancer, and setting.
- Pancreatic cancer early detection · 2026AI and Pancreatic Cancer Detection: What Earlier Scan Findings Can—and Cannot—ShowAI models may find subtle patterns on earlier CT scans. Retrospective success does not yet prove a screening program will save lives.
- AI-assisted mammography · 2026AI in Mammography: A Second Reader, Not a Final AnswerAI may help radiologists review mammograms, but it does not remove the need for human interpretation, follow-up, or careful validation.
- AI and early cancer detection · 2026AI and Earlier Cancer Detection: Earlier Is Helpful Only When Outcomes ImproveAI may flag subtle patterns before symptoms appear. Screening value also depends on false results, overdiagnosis, follow-up, and mortality.
- Artificial intelligence and cancer detection · 2026AI Cancer Detection: What a Strong Study Must ShowAI can find patterns in scans and pathology images, but useful cancer detection requires careful testing in real patients and clinical settings.
- Artificial sweeteners, cancer risk, and what this study did and did not measure · 2025Sweeteners and Thinking Skills: What the 8-Year Brazilian Study FoundA Neurology study linked higher low-calorie sweetener intake to faster cognitive decline. What it found, what it cannot show, and why it is not a cancer study.
- Dental care during cancer treatment · 2026A Brush-On Cavity Treatment Passed Its Big U.S. Trial — and Why That Matters in Cancer CareA U.S. trial found 38% silver diamine fluoride stopped decay in about half of treated baby teeth, with no drill and no shot. What it does and doesn't show.
- Bacterial cancer therapy and how to read a viral science headline · 2026Did Scientists Cure Cancer With Frog Bacteria?A Short titled "Scientists Cure Cancer By Injecting Frog Bacteria" has millions of views. The study behind it is real. Every result in it is from mice.
- study-literacy · 2026What Patients Should Ask After an AI Cancer HeadlineAI cancer headlines can sound decisive. This original explainer gives patients questions about validation, errors, bias, and clinical use.
- patient-questions · 2026What Patients Should Ask After an Antibody-Drug Conjugate HeadlineAntibody-drug conjugate headlines can sound like precision magic. Patients should ask about target, payload, cancer type, and side effects.
- response rate · 2026Cancer Study Headline, Translated: Response RateHow to read cancer study headlines about response rate, tumor shrinkage, durability, side effects, and trial phase.
- quality-of-life endpoints · 2026Cancer Study Headline, Translated: Quality-of-Life EndpointWhat quality-of-life endpoints can add to cancer trial headlines, and what they cannot tell one patient by themselves.
- progression-free survival · 2026Cancer Study Headline, Translated: Progression-Free SurvivalA plain-language research explainer for progression-free survival headlines and what patients should ask before applying the result.
- study-literacy · 2026Research Headline: Mouse Study vs Human TrialA study-literacy news explainer on why promising mouse cancer research is not the same as a treatment proven in people.
- study-literacy · 2026Research Headline: Liquid Biopsy Results ExplainedA research-news explainer on liquid biopsy headlines, ctDNA, measurable disease, and what patients should ask next.
- study-literacy · 2026Cancer Study Headline, Translated: When RECIST and PFS Show UpStudy headlines often mention RECIST, response rate, and progression-free survival. Here is what those terms can and cannot tell patients.
- study headlines · 2026Cancer Study Headline, Translated: Median SurvivalA plain-language explainer for cancer headlines that report median survival, including what the number means and what it does not predict for one person.
- study-literacy · 2026Cancer Study Headline, Translated: Absolute vs Relative RiskA plain-language news analysis explaining why absolute risk and relative risk can make the same cancer study headline feel very different.
- Cancer imaging research · 2026New Mouse Imaging Method Links Whole-Body Tumor Scans to Cell-Level DetailResearchers reported a mouse-model imaging system that connects whole-body tumor tracking with cell-level detail. What it may help scientists study, and what it does not mean for patients yet.
- Comparative oncology · 2026A Tumor-Prone Gecko Is Giving Cancer Researchers a New ModelA BMC Biology study reported genomic clues from lemon frost leopard geckos, a color morph with very high rates of pigment-cell tumors. It is comparative oncology research, not a human treatment.
- Colorectal cancer and the microbiome · 2026Gut Bacteria, a Toxin, and Colon Cancer: What a New Mechanism Study FoundA Nature study identified claudin-4 as a receptor that helps a Bacteroides fragilis toxin damage colon cells. It is mechanistic research, not a new screening test or treatment.
- CAR T-cell therapy · 2026What Is CAR T-Cell Therapy? The Treatment Making Headlines, ExplainedCAR T-cell therapy uses a person's own immune cells to fight cancer. Here's what it is, which cancers it treats, and what to keep in mind.
- Liquid biopsy · 2026What Is a 'Liquid Biopsy'? The Blood Test Behind Cancer HeadlinesLiquid biopsy is a blood test that looks for cancer's fingerprints in the bloodstream. Here's what it is, how it's used, and its current limits.
- Alcohol and cancer risk · 2026The Surgeon General's 2025 Advisory on Alcohol and Cancer, ExplainedIn January 2025, the U.S. Surgeon General issued an advisory linking alcohol to cancer risk. Here's what it says and what the science behind it shows.
- Tobacco and cancer · 2026U.S. Smoking at Historic Lows: What It Means for CancerThe U.S. adult smoking rate has fallen below 10% for the first time. Here's why that's such good news for cancer — and the caveats that remain.
- Multi-cancer early detection · 2026Multi-Cancer Early Detection Blood Tests: What They Are and Why They Are Still Being StudiedA single blood test that screens for many cancers sounds ideal. Here's what multi-cancer early detection tests are, and why experts say the evidence isn't in yet.
- Cancer vaccine research · 2026mRNA Cancer Vaccines: Promising Research, Not Yet a Treatment You Can GetTrials of personalized mRNA vaccines for melanoma have shown encouraging results. Here's what they are — and why they're still experimental.
- HPV vaccination · 2026Real-World Evidence: HPV Vaccination Is Driving Down Cervical CancerStudies now show cervical cancer and precancers falling in vaccinated young women. Here's what the real-world evidence shows about the HPV vaccine.
- Cervical cancer screening · 2026FDA Approves Self-Collection for HPV Testing: What It Means for Cervical ScreeningIn 2024, the FDA approved HPV self-collection in health care settings. Here's what that is and how it could widen access to cervical cancer screening.
- Cancer statistics · 2026U.S. Cancer Death Rates Keep Falling: What the ACS 2025 Report ShowsThe American Cancer Society's 2025 statistics report shows the cancer death rate has dropped sharply since 1991. Here's what's behind the progress — and the caveats.
- Early-onset cancer · 2026Why Cancer Rates Are Rising in Adults Under 50: A Calm Look at Early-Onset CancerReports show some cancers rising among younger adults. Here's what 'early-onset cancer' means, what researchers know, and what remains uncertain.
- Colorectal cancer screening · 2026Colorectal Cancer Screening Now Starts at 45: Why the Age DroppedGuidelines now recommend colorectal cancer screening begin at age 45, not 50. Here's what changed and why.
- Breast density · 2026Your Mammogram Report Now Tells You About Breast Density: The 2024 FDA RuleAs of September 2024, mammogram reports must include breast density. Here's what breast density is and why the FDA now requires you be told.
- Breast cancer screening · 2026Breast Cancer Screening Now Starts at 40: What the 2024 USPSTF Update MeansIn 2024, the U.S. Preventive Services Task Force lowered the recommended start age for routine mammograms to 40. Here's what changed and why.
- AI in breast cancer screening · 2026AI to Help Read Mammograms: What Trials Show — and What It Doesn't ReplaceStudies are testing artificial intelligence as a tool to help read mammograms. Here's what the research shows and why it isn't replacing radiologists.
- Precision medicine · 2026What Is Precision Medicine in Cancer?Precision medicine and 'personalized' cancer treatment are common in the news. Here's what these terms mean, straight from NCI, and where they fit in cancer care today.
- Metastatic cancer · 2026What Is Metastasis? Understanding When Cancer SpreadsNews stories often mention that a cancer has 'metastasized' or is 'stage 4.' Here's what metastasis actually means, in plain language from NCI.
- Immunotherapy · 2026What Is Immunotherapy? Understanding a Term You See in Cancer NewsImmunotherapy is one of the most talked-about cancer treatments. Here's what it actually is, the main types, and what NCI says about how it works.
- Biomarker testing · 2026What Is Biomarker Testing for Cancer Treatment?You'll hear about biomarker testing, tumor profiling, and 'matching' treatments to a person's cancer. Here's what biomarker testing is and how it guides treatment choices.
- Tumor markers · 2026What Is a Tumor Marker? Making Sense of a Term You See in Cancer NewsNews stories sometimes mention a tumor marker or a blood test that 'detects cancer.' Here's what tumor markers actually are, and what they can and can't tell you.
- Remission and survivorship · 2026What Does Cancer Remission Mean? Remission vs. Cure, ExplainedYou often see the word remission in the news when someone finishes cancer treatment. Here's what remission actually means, and how it's different from being cured.
- Clinical trials · 2026How to Read Cancer Clinical Trial NewsNew cancer trial results make headlines constantly. Here's what clinical trials are, the different types, and how to read the coverage with a calm, informed eye.
- Cancer statistics · 2026Understanding Cancer Survival Statistics in the NewsCancer statistics appear in headlines all the time. Here's what they measure, why trends matter more than single numbers, and why they don't predict any one person's outcome.
- Cancer research & clinical trials · 2026"Breakthrough," "Cure," "Game-Changer": How to Read Cancer Research HeadlinesCancer research headlines trend almost weekly. Here is a calm guide to understanding what a study result does and does not mean.
- Hereditary cancer and genetic testing · 2026Does Cancer Run in Families? Understanding Hereditary Cancer and Genetic TestingNews about BRCA genes and genetic testing can make it seem like cancer is simply inherited. Here's what NCI says about hereditary cancer risk and what testing can tell you.
- Cancer prevention · 2026Can Cancer Be Prevented? What the Research Actually ShowsHeadlines constantly promise ways to prevent cancer. Here's what NCI actually says about known risk factors, what lowers risk, and what hasn't been shown to help.
💛 Support free cancer education
Cancer Explained is free for everyone. Donations help us keep creating calm, plain-language explanations based on trusted National Cancer Institute resources.